Wellington Management Group LLP Acquires 8,400,208 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Wellington Management Group LLP lifted its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 84.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 18,325,123 shares of the company’s stock after acquiring an additional 8,400,208 shares during the period. Wellington Management Group LLP owned 11.08% of Option Care Health worth $425,143,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in OPCH. Murphy & Mullick Capital Management Corp bought a new stake in shares of Option Care Health in the 4th quarter valued at approximately $26,000. UMB Bank n.a. raised its holdings in Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after buying an additional 346 shares during the period. Signaturefd LLC lifted its position in Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock worth $28,000 after buying an additional 1,005 shares during the last quarter. Quarry LP boosted its stake in Option Care Health by 327.7% during the third quarter. Quarry LP now owns 3,430 shares of the company’s stock worth $107,000 after buying an additional 2,628 shares during the period. Finally, Blue Trust Inc. increased its position in Option Care Health by 16.9% during the fourth quarter. Blue Trust Inc. now owns 4,703 shares of the company’s stock valued at $109,000 after acquiring an additional 681 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Stock Up 0.6 %

Shares of NASDAQ OPCH opened at $34.95 on Tuesday. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53. The firm has a market capitalization of $5.74 billion, a price-to-earnings ratio of 29.37, a PEG ratio of 2.30 and a beta of 1.33. The stock has a 50 day moving average price of $32.58 and a 200 day moving average price of $28.40. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on OPCH. Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and raised their target price for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. JMP Securities reissued a “market outperform” rating and issued a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and upped their target price for the company from $26.00 to $33.00 in a research note on Monday, January 13th. UBS Group assumed coverage on Option Care Health in a report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price target on the stock. Finally, Barrington Research boosted their price objective on Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a report on Thursday, February 27th. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat, Option Care Health currently has an average rating of “Moderate Buy” and a consensus price target of $33.00.

Insiders Place Their Bets

In other news, insider Michael Bavaro sold 30,996 shares of the company’s stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares of the company’s stock, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.64% of the stock is owned by company insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.